Why Spark’s CEO says 2017 may be a ‘historic year’ for his gene therapy company – Philadelphia Business Journal


Philadelphia Business Journal
Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company
Philadelphia Business Journal
Philadelphia gene therapy company Spark Therapeutics said it is in the final stages of completing its rolling biologics license application for its lead product: a one-time treatment for an inherited retinal disease that causes blindness in children ...
Spark Therapeutics Reports 2016 Financial Results and Business HighlightsGlobeNewswire (press release)
Spark Therapeutics Inc. (ONCE) Plunges 5.15% on February 22Equities.com
Spark Therapeutics, Inc.'s (ONCE) CEO Jeffrey Marrazzo on Q4 2016 Results - Earnings Call TranscriptSeeking Alpha
Highland Mirror -The Cerbat Gem
all 22 news articles »

Read this article:

Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company - Philadelphia Business Journal

Related Posts

Comments are closed.